South Korea to Keep Discussing Forex With US After Currency List
South Korea will continue to discuss its foreign exchange policy with the US to promote mutual understanding, after the Treasury kept the Asian ally on its watchlist and called for curbing currency intervention.
The Treasury Department, in a semiannual foreign-exchange report released Thursday, didn't label any country a currency manipulator but kept South Korea on its monitoring list for currency practices alongside China and Japan, among other countries.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
28 minutes ago
- Fox News
Business Rundown: High State Trade Talks Between U.S., China Began
Kicking off what will no doubt be a big week in economic news, the White House's top trade officials are meeting with their Chinese counterparts in London. Their goal is to end the ongoing trade war and reach a deal that will provide a much-needed boost to America's manufacturers. While we're coming off a better-than-expected May jobs report, the stakes remain high for Treasury Secretary Scott Bessent, Commerce Secretary Howard Lutnick, and Trade Representative Jamieson Greer, as Wall Street and Main Street have been somewhat anxious about President Trump's tariff strategy. Also, on the minds of investors, this week's inflation report, the fallout from the President's fallout with Elon Musk, and the fate of that one big beautiful bill. Lou Basenese, the Executive Vice President of Market Strategy at Prairie Operating, joins FOX Business Network's Lydia Hu to discuss the importance of the U.S.-China trade talks, Wednesday's inflation data, and the other big stories that could move the market this week. Learn more about your ad choices. Visit
Yahoo
30 minutes ago
- Yahoo
AMD price target lift, Apple's WWDC, Chewy downgrade
Market Domination co-host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute. Advanced Micro Devices (AMD) stock gains after Citi lifts its price target to $120 from $100, citing upcoming artificial intelligence (AI) catalysts and advantages over Nvidia (NVDA). Apple (AAPL) is kicking off its Worldwide Developers Conference on Monday, where the company is expected to unveil key software updates. Chewy (CHWY) stock slides after Mizuho downgraded the stock to Neutral from Outperform. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute. It's time for Yahoo Finance's market minute. US stocks seesaw as investors eye renewed US-China trade talks. Wall Street looking for signs of either side willing to dial down tensions and reach a tariff deal. AMD shares getting a lift as City raises its price target on that stock from 100 to 120. City highlighting potential positive catalyst, the second half of the year and sees the chip maker as having some advantages over Nvidia. The price target change comes ahead of AMD's advancing AI event, which is taking place on June 12th. Apple kicking off its worldwide developers conference on Monday. The iPhone maker offering a look at the changes coming to the company's software products throughout the next year. Apple expected to reveal software and design updates. And Chewy shares, they're sliding as Mizuho hits the stock with a downgrade, lowering its rating from outperform to neutral. Mizuho citing the pet food company's unattractive positioning, noting quote, several potential landmines for the first quarter. And that's your Yahoo Finance market minute. Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
June 2025's Spotlight On Promising Penny Stocks
As the U.S. stock market experiences a rally fueled by optimism over U.S.-China trade talks and robust corporate earnings, investors are increasingly exploring diverse investment opportunities. Penny stocks, a term that may seem outdated yet remains relevant, represent shares of smaller or newer companies that can offer significant growth potential when backed by strong financial health. In this article, we will explore several penny stocks that demonstrate balance sheet strength and long-term potential, providing investors with opportunities to uncover hidden value in the market. Name Share Price Market Cap Financial Health Rating Imperial Petroleum (IMPP) $3.02 $103.93M ★★★★★★ New Horizon Aircraft (HOVR) $0.935 $29.35M ★★★★★★ Waterdrop (WDH) $1.475 $533.45M ★★★★★★ Greenland Technologies Holding (GTEC) $2.06 $35.83M ★★★★★★ WM Technology (MAPS) $1.11 $186.68M ★★★★★★ Perfect (PERF) $1.815 $184.86M ★★★★★★ Table Trac (TBTC) $4.86 $22.55M ★★★★★★ Flexible Solutions International (FSI) $4.32 $54.64M ★★★★★★ BAB (BABB) $0.8311 $6.04M ★★★★★★ Lifetime Brands (LCUT) $3.43 $76.88M ★★★★★☆ Click here to see the full list of 709 stocks from our US Penny Stocks screener. Let's review some notable picks from our screened stocks. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Aldeyra Therapeutics, Inc. is a biotechnology company focused on discovering and developing therapies for immune-mediated and metabolic diseases, with a market cap of approximately $159.32 million. Operations: Aldeyra Therapeutics, Inc. does not report any revenue segments. Market Cap: $159.32M Aldeyra Therapeutics, with a market cap of US$159.32 million, is a pre-revenue biotechnology firm navigating the challenging landscape of clinical trials and regulatory approvals. Despite recent setbacks from the FDA regarding its dry eye treatment candidate reproxalap, the company achieved significant milestones in Phase 3 trials that may address previous concerns. Financially, Aldeyra maintains strong short-term liquidity with US$92.7 million in assets against liabilities and has more cash than debt, providing a runway exceeding one year. However, high volatility and ongoing losses highlight inherent risks typical for companies at this developmental stage in the biotech sector. Unlock comprehensive insights into our analysis of Aldeyra Therapeutics stock in this financial health report. Explore Aldeyra Therapeutics' analyst forecasts in our growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Maravai LifeSciences Holdings, Inc. is a life sciences company that offers products supporting the development of drug therapies, vaccines, cell and gene therapies, and diagnostics across various global regions with a market cap of $608.64 million. Operations: The company generates revenue primarily from Nucleic Acid Production, which accounts for $179.08 million, and Biologics Safety Testing, contributing $62.78 million. Market Cap: $608.64M Maravai LifeSciences Holdings, with a market cap of US$608.64 million, faces challenges typical for penny stocks, including recent declines in sales and increased net losses. The company reported first-quarter sales of US$46.85 million, down from US$64.18 million a year prior, and a net loss of US$29.95 million compared to the previous year's US$12.08 million loss. Despite its unprofitability, Maravai has strong short-term liquidity with assets surpassing both short- and long-term liabilities and has reduced its debt-to-equity ratio over five years from 262.7% to 55.6%, indicating improved financial management amidst volatility concerns. Navigate through the intricacies of Maravai LifeSciences Holdings with our comprehensive balance sheet health report here. Assess Maravai LifeSciences Holdings' future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Ranpak Holdings Corp. offers product protection and end-of-line automation solutions for e-commerce and industrial supply chains across North America, Europe, and Asia, with a market cap of approximately $306.61 million. Operations: The company generates $374.8 million in revenue from its product protection and automation solutions for e-commerce and industrial supply chains. Market Cap: $306.61M Ranpak Holdings, with a market cap of US$306.61 million, exemplifies the volatility and potential of penny stocks. Despite being unprofitable with increasing losses over five years and a negative return on equity, Ranpak maintains a seasoned management team and board. The company reported first-quarter revenue growth to US$91.2 million but also faced a net loss of US$10.9 million. Recent strategic partnerships, like the one with Thalia for automated packaging systems, highlight its commitment to innovation in e-commerce fulfillment solutions while managing high debt levels and maintaining sufficient cash runway for over three years. Click to explore a detailed breakdown of our findings in Ranpak Holdings' financial health report. Understand Ranpak Holdings' earnings outlook by examining our growth report. Explore the 709 names from our US Penny Stocks screener here. Ready To Venture Into Other Investment Styles? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ALDX MRVI and PACK. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
